Editorial

False-Positive Urine Drug Screens: Clinical Challenges and Confirmatory Testing

Abstract

N/A

Masternak S, Padała O, Karakuła-Juchnowicz H. False-positive drug test results in patients taking psychotropic drugs. A literature review. Psychiatria Polska. 2021;55(2):435-446.

Brahm NC, Yeager LL, Fox MD, Farmer KC, Palmer TA. Commonly prescribed medications and potential false-positive urine drug screens. Am J Health Syst Pharm. 2010;67(16):1344-1350.

Kale N. American Academy of Family Physicians. Urine drug tests: ordering and interpretation. Am Fam Physician. 2019;99(1):33-39.

Melanson SE. The utility of immunoassays for urine drug testing. Clin Lab Med. 2012;32(3):429-447.

Reschly-Krasowski JM, Krasowski MD. A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing. Acad Pathol. 2018;5: 2374289518811797.

Poklis A, Hall KV, Still J, Binder SR. Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay. J Anal Toxicol. 1991;15(2):101-103.

Casey ER, Scott MG, Tang S, Mullins ME. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay. J Med Toxicol. 2011;7(2):105-108.

Dasgupta A. False-positive benzodiazepine immunoassay screen result caused by sertraline (Zoloft). Am J Clin Pathol. 2002;118(3):408-411.

Bogusz MJ, Hassan H, Al-Enazi E, Ibrahim Z, Al-Tufail M. Urine drug screening of zonisamide: evaluation of cross-reactivity with benzodiazepine immunoassays. J Anal Toxicol. 2011;35(6):348-352.

Snyder ML, Carter S, Holthoff G. False-positive tricyclic antidepressant immunoassay screen result caused by quetiapine (Seroquel). J Clin Psychiatry. 2010;71(1):140-141.

Poklis A, Hall KV, Still J. The effect of levofloxacin on urine opiate screening tests. JAMA. 2002;288(24):3115.

Chen HH, Kuo YH, Wu LS. Dextromethorphan producing false-positive phencyclidine results in a rapid urine drug screen. Clin Toxicol (Phila). 2008;46(8):768-769.

Brahm NC, Palmer TA. Diphenhydramine interference with a methadone immunoassay. Ann Pharmacother. 2010;44(4):748-749.

Rollins DE, Jennison TA, Jones G. Investigation of interference by ibuprofen in the EMIT-d.a.u. cannabinoid assay. J Anal Toxicol. 1989;13(4):240-242.

Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66-76.

Schwebach A, Ball J. Urine Drug Screening: Minimizing False-Positives and False-Negatives to Optimize Patient Care. US Pharm. 2016;41(8):26-30.

Eldooma I, Maatoug M, Yousif M. Outcomes of Pharmacist-Led Pharmaceutical Care Interventions Within Community Pharmacies: Narrative Review. Integr Pharm Res Pract. 2023;12:113-126.

Wilandika A, Pandin MGR, Yusuf A. The roles of nurses in supporting health literacy: a scoping review. Front Public Health. 2023;11:1022803.

Files
IssueVol 13, No 3 (Summer 2025) QRcode
SectionEditorial
DOI https://doi.org/10.18502/jpc.v13i3.20317
Keywords
Urine Drug Screening False-Positive Immunoassay Multidisciplinary

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Ghaeli P. False-Positive Urine Drug Screens: Clinical Challenges and Confirmatory Testing. J Pharm Care. 2025;13(3):148-149.